Turku Bioscience News

    MicroRNAs may reveal type 1 diabetes

    June 26, 2023

    MicroRNAs are short RNA strands, of which more than 2,300 have been identified in humans. Their abnormal expression contributes to the development of many diseases, Read more

    Johanna Ivaska has been selected to join Academia Europaea as an invited member

    June 6, 2023

    Academia Europaea is a European, non-governmental association acting as an Academy which covers all disciplines and invites distinguished scientists to become members based on peer Read more

    Researchers Identify Gene Expression Signature That Predicts Progression of Type 1 Diabetes

    May 31, 2023

    Researchers from Turku Bioscience Centre and InFLAMES Flagship at the University of Turku in Finland, have identified a gene expression signature that can predict the Read more

    SAVE THE DATE: BioCity PhD Mini-Symposium is coming!

    May 26, 2023

    A team of Doctoral Researchers are delighted to announce the BioCity PhD Mini-Symposium planned on the afternoon before the main symposium, i.e., on Wednesday 23rd August, 2023. This will Read more

    Mikael Knip of the University of Helsinki is conferred as a Turku University Honorary Doctor in medicine

    May 25, 2023

    Mikael Knip of the University of Helsinki is conferred as a Turku University honorary doctor in medicine for his merits in the research of type Read more

    Turku Bioscience funding news May 2023

    May 23, 2023

    We are delighted to share the following funding news with everyone. Warmest congratulations to those who got funded. BioCity Turku Collaborative Research Funding Call Results All funded projects are listed here: https://biocityturku.fi/research-programs/

    The EURAS project received over 8 million euros funding from the Health Cluster of the Horizon Europe Research and Innovation Programme

    May 23, 2023

    The EURAS consortium received Horizon funding to develop new treatments for rare neurodevelopmental disorders of the Ras pathway.

    A position on the EURAS project is now open for applications (deadline extended until 1 August 2023)

    May 16, 2023

      Our lab has now opened a position to join us on the EURAS consortium project. The deadline for applications is now extended until 1 August 2023. The description and application links can be found Read more

    The EURAS project has been awarded ~8 million euros funding from the Health Cluster of the Horizon Europe Research and Innovation Programme

    May 12, 2023

    Rare neurodevelopmental disorders of the Ras pathway continue to evade effective treatment. The EURAS consortium has been awarded ~8 million euros from the Health Cluster of the Horizon Europe Research and Innovation Programme to develop Read more

    DDCB symposium on May 4th 2023

    May 4, 2023

    How could your research benefit from the chemical biology and drug discovery tools and infrastructure available in Finland? Find out on 4th May 2023 at the symposium held by the Drug Discovery and Chemical Biology Read more

    Coming soon: The EURas consortium grant agreement has now been signed, new recruitment will open soon

    April 25, 2023

    The European network for neurodevelopmental Rasopathies, consisting of 16 partners across Europe, is about to formally begin. Our laboratory will be recruiting one researcher at postdoc or graduate student levels to identify robust phenotypic differences Read more

    Dissertation defence (Pathology): MSc Srikar Nagelli

    April 11, 2023

    MSc Srikar Nagelli defends his dissertation in Pathology entitled “CIP2A is a critical DNA damage response protein that drives basal-like breast cancer” at the University Read more